Zobrazeno 1 - 10 of 14 pro vyhledávání: '"Anna Farriols"'
1
Akademický článek
Use of Drugs in Clinical Practice and the Associated Cost of Cancer Treatment in Adult Patients with Solid Tumors: A 10-Year Retrospective Cohort Study
Autor: Maria-Josep Carreras, Elena Tomás-Guillén, Anna Farriols, Berta Renedo-Miró, Carolina Valdivia, Jana Vidal, Cristina Saura, Joan Carles, Enriqueta Felip, Maria-Queralt Gorgas, Josep Tabernero, Josep Monterde
Publikováno v: Current Oncology, Vol 30, Iss 9, Pp 7984-8004 (2023)
Background: Cancer is one of the leading causes of morbidity and mortality in the world. Its growing incidence and prevalence, as well as the advances in diagnostic and treatment tools, motivate an open debate about the economic burden it may place o
Externí odkaz: https://doaj.org/article/693da0fcbdaa4f0cad78276db01bf51c
Zobrazit plný text záznamu
2
Akademický článek
Incidence and characteristics of adverse drug reactions in a cohort of patients treated with PD-1/PD-L1 inhibitors in real-world practice
Autor: Mònica Sabaté Gallego, Eulàlia Pérez Esquirol, Núria Garcia Doladé, Xavier Vidal Guitart, Maria-Josep Carreras Soler, Anna Farriols Danés, Enriqueta Felip, Irene Braña, Joan Carles Galceran, Rafael Morales Barrera, Eva Muñoz-Couselo, Antònia Agustí Escasany
Publikováno v: Frontiers in Medicine, Vol 9 (2022)
BackgroundData related to adverse drug reactions (ADRs), specifically immune-related adverse events (irAEs), in long-term treatment with immunotherapy in real-world practice is scarce, as is general information regarding the management of ADRs.Object
Externí odkaz: https://doaj.org/article/f405c5d1f55f4aa1876d916781d4919b
Zobrazit plný text záznamu
3
Akademický článek
The Low Incidence of Viral Hepatitis Reactivation Among Subjects on Immunotherapy Reduces the Impact of Suboptimal Screening Rate
Autor: Laia Aceituno, Juan Bañares, Lourdes Ruiz-Ortega, Ana Callejo-Pérez, Eva Muñoz-Couselo, Carolina Ortiz-Velez, Nely Díaz-Mejía, Ana Barreira-Díaz, María José Carreras, Anna Farriols, María Buti, Mar Riveiro-Barciela
Publikováno v: Frontiers in Medicine, Vol 9 (2022)
Background and AimsImmunotherapy with immune checkpoint inhibitors (ICIs) is a pillar of many advanced tumors. However, there is scarce data concerning the rate of viral hepatitis screening in this population or the risk of viral reactivation.Methods
Externí odkaz: https://doaj.org/article/8adbd67a6ece4095ba87e2b28faf0461
Zobrazit plný text záznamu
6
An electronic alert system increases screening for hepatitis B and C and improves management of patients with haematological disorders
Autor: Paula Gubern, Luisa Roade, Maria Buti, Francesc Bosch, María José Carreras, Anna Farriols, Rafael Esteban, Pau Abrisqueta, Mar Riveiro-Barciela
Publikováno v: Scientific Reports
Scientia
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Hepatitis B; Hepatitis C Hepatitis B; Hepatitis C Hepatitis B; Hepatitis C Treatment of haematological disorders in patients with chronic hepatitis B or resolved infection (anti-HBc-positive) is associated with a risk of hepatitis B reactivation. Mor
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9ba573581add5b28e9c3058d3122ba4
https://doi.org/10.1038/s41598-020-59476-4
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje